Zydus receives approval to conduct Phase III trials of Zintrodiazine for malaria in India
Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmodium vivax infections
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Zydus Lifesciences
Zydus expands companion diagnostics portfolio with launch of AI-powered Continuous Glucose Monitor
Zydus Lifesciences, an innovation-led global life sciences company, today announced its new offering companion diagnostics…
Zydus Lifesciences to launch Semaglutide Injection in India after patent expiry
Company plans rollout under SEMAGLYN, MASHEMA and ALTERME brands with adjustable single-pen device
Zydus Lifesciences launches Anyra, biosimilar of Aflibercept 2 mg in India
Company signs agreement with Regeneron Pharmaceuticals and Bayer for ophthalmic therapy
USFDA grants orphan drug designation to Zydus’ Desidustat for sickle cell disease
Designation covers oral HIF-PHI therapy for SCD
Zydus launches the world’s first biosimilar of Nivolumab, ‘Tishtha’, in India to treat multiple…
Zydus Lifesciences, an innovation-led life-sciences company with an international presence has launched the world’s first…
Zydus Lifesciences signs licensing deal with Formycon
Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lifesciences will commercialise the product in the USA…
Zydus Lifesciences receives USFDA approval for Diroximel Fumarate delayed-release capsules
The approval covers the treatment of relapsing forms of multiple sclerosis in adults, with production to take place at Zydus…
Zydus receives NMPA approval in China for Venlafaxine extended-release capsules
This marks the first NMPA approval for Zydus in the Chinese market
IPA announces leadership transition
Sharvil Patel, MD, Zydus Lifesciences and former VP, IPA, assumes the role of President,; Glenn Saldanha, Chairman and MD,…